Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Positive phase I/II results reported for adenoviral p53 gene therapy

Nov. 26, 1997

DNA-intercalating agents reported by Mitsui Toatsu in patent literature

Nov. 25, 1997

Daiichi synthesizes paclitaxel derivatives

Nov. 25, 1997

Axiom, Zaiya and Nippon Kagaku anticancer drug discovery alliance

Nov. 25, 1997

Techniclone reacquires rights to Oncolym

Nov. 25, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

New antitumor compound QM16-A described in patent literature

Nov. 21, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...